Clinical Trials Logo
  1. Home
  2. Cardiovascular Disease
  3. NCT00590798
  4. Details
NCT00590798 Clinical Trial

Star-Close Early Ambulation Trial

Cardiovascular Disease Clinical Trial

— STRUT  

Official title:
Star-Close Early Ambulation Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00590798
Other study ID # STRUT
Secondary ID
Status Completed
Phase N/A
First received December 26, 2007
Last updated April 9, 2013
Start date April 2007
Est. completion date December 2008

Study information
Verified date April 2013
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

To confirm that patients who receive the Star-Close vascular closure system (VCS) can safely ambulate within 30 minutes of catheterization.

Description:

To confirm that patients who receive the Star-Close vascular closure system (VCS) after diagnostic cardiac catheterization can safely ambulate within 30 minutes of catheterization.

Recruitment information / eligibility
Status Completed
Enrollment 58
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients admitted to for an outpatient left heart catheterization

- Catheterization through the femoral artery

- Able to ambulate at least 20 feet

- Able to receive the Star-Close Vascular Closure System

- Be a candidate for hospital discharge following catheterization

Exclusion Criteria:

- Known peripheral arterial disease

- Blood pressure greater than 180/110

- Pregnant or lactating

- Anemic or low blood count

- Blood thinning medication within 5 days before catheterization

- Unable to walk 20 feet with out rest

- Complications during catheterization procedure

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Intervention

Behavioral:
• Walking
Patient will walk within 30 minutes of vascular closure system procedure

Locations
Country Name City State
United States The Ohio State University Medical Center Columbus Ohio

Sponsors (1)
Lead Sponsor Collaborator
Ernest Mazzaferri

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Occurrence or absence of adverse outcomes after ambulation within 30 minutes of cardiac catheterization 7 days post procedure Yes
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Completed NCT02502812 - Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects Phase 1
Recruiting NCT04216342 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers Phase 1
Completed NCT03654313 - Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Phase 1
Completed NCT03646656 - Heart Health Buddies: Peer Support to Decrease CVD Risk N/A
Completed NCT02081066 - Identification of CETP as a Marker of Atherosclerosis N/A
Completed NCT02147626 - Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Recruiting NCT03095261 - Incentives in Cardiac Rehabilitation N/A
Not yet recruiting NCT02578355 - National Plaque Registry and Database N/A
Completed NCT02868710 - Individual Variability to Aerobic Exercise Training N/A
Completed NCT02711878 - Healing Hearts and Mending Minds in Older Adults Living With HIV N/A
Completed NCT02589769 - Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons N/A
Completed NCT02998918 - Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL N/A
Recruiting NCT02885792 - Coronary Artery Disease in Patients Suffering From Schizophrenia N/A
Completed NCT02657382 - Mental Stress Ischemia: Biofeedback Study N/A
Completed NCT02272946 - Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Phase 2
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Completed NCT02640859 - Investigation of Metabolic Risk in Korean Adults
Recruiting NCT02265250 - Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment